Orange Book product · Generic (ANDA)
BUPIVACAINE LIPOSOME
BUPIVACAINE
Generic (ANDA)ANDA 214348DISCN HENGRUI PHARMA
At a glance
Jul 01, 2024
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jul 01, 2024
2 yr ago
Today
Pharmaceutical detail
Active ingredient
BUPIVACAINE
Strength
133MG/10ML (13.3MG/ML)
Dosage form
INJECTABLE, LIPOSOMAL
Route
INJECTION
TE code
Not listed
Application
ANDA 214348
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of BUPIVACAINE
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
